Avidity Biosciences
271 hedge funds and large institutions have $7.01B invested in Avidity Biosciences in 2025 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 113 increasing their positions, 57 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
32% more funds holding
Funds holding: 206 → 271 (+65)
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
2.5% less ownership
Funds ownership: 112.82% → 110.32% (-2.5%)
Holders
271
Holding in Top 10
9
Calls
$64.1M
Puts
$26.9M
Top Buyers
| 1 | +$235M | |
| 2 | +$173M | |
| 3 | +$163M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$93.8M |
| 5 |
RI
RTW Investments
New York
|
+$76.4M |
Top Sellers
| 1 | -$100M | |
| 2 | -$44.5M | |
| 3 | -$15.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.2M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$13.6M |
